DIAMEDICA THERAPEUTICS INC's ticker is DMAC and the CUSIP is 25253X207. A total of 37 filers reported holding DIAMEDICA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.1%.
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Stonepine Capital Management, LLC | 419,942 | $1,869,000 | 0.98% |
Manatuck Hill Partners, LLC | 570,500 | $2,539,000 | 0.77% |
Corriente Advisors, LLC | 203,641 | $906,000 | 0.49% |
JACOB ASSET MANAGEMENT OF NEW YORK LLC | 275,000 | $1,224,000 | 0.40% |
Ikarian Capital, LLC | 415,000 | $1,847,000 | 0.15% |
COOPERMAN LEON G | 50,000 | $223,000 | 0.01% |
BOOTHBAY FUND MANAGEMENT, LLC | 46,562 | $207,000 | 0.01% |
Trexquant Investment LP | 17,019 | $76,000 | 0.01% |
TWO SIGMA SECURITIES, LLC | 30,511 | $136,000 | 0.00% |
MARSHALL WACE, LLP | 155,662 | $693,000 | 0.00% |